Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Osamu Sakai

Neuroradiology Boston, MA Medical Doctor

NPI 1770550956 CMS profile 1039969

88 E Newton St, Dept Radiology, Boston, MA 02118

Open in the dashboard

General payments

$84,410

90 records reported · program years 2019–2025

Research payments

$137,226

Paid to them · 20 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$97,203 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Osamu Sakai of Boston, MA is reported in the CMS Open Payments database as having received $84,410 across 90 general payments and $137,226 in research payments paid to them. Separately, studies naming them as principal investigator received $97,203 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Neuroradiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,000 1
2025 Research $110,937 19
2024 General $1,500 1
2024 Research $26,289 1
2023 General $1,000 1
2021 General $7,765 21
2020 General $33,905 35
2019 General $39,240 31

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Osamu Sakai
  • Neuroradiology median
  • Middle half of Neuroradiology
  • National median

In program year 2025, general payments to Osamu Sakai were reported at $1,000. Among 399 Neuroradiology profiles paid that year, the median was $279 and the middle half received between $65 and $2,205.

Show as a table
Year Osamu Sakai Neuroradiology median Middle half National median
2019 $39,240 $288 $71–$2,035 $163
2020 $33,905 $165 $32–$1,794 $114
2021 $7,765 $238 $42–$1,807 $132
2022 $0 $191 $49–$1,388 $149
2023 $1,000 $228 $56–$1,148 $160
2024 $1,500 $241 $97–$2,192 $164
2025 $1,000 $279 $65–$2,205 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Merck Sharp & Dohme Corporation $51,230 75 payments
  2. Pfizer Inc. $29,680 12 payments
  3. Eli Lilly and Company $3,500 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $84,410 90 payments
Products named General payments · program years 2019–2025
  1. KEYTRUDA $51,230 75 payments
  2. BAVENCIO $18,520 3 payments
  3. LORBRENA $11,160 9 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. GlaxoSmithKline, LLC. $137,226 20 payments

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$85,681

Of which drugs: $275

Medicare patients

1,200

Average age 74

Services billed

4,610

655 women, 545 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 53%
Ischemic heart disease 32%
Depression 31%
Chronic kidney disease 27%
Cancer 27%
Diabetes 25%
Atrial fibrillation 24%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, gadoterate meglumine, 0.1 ml A9575 Office 15 2,380 $203

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

110 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neuroradiology in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record